Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoglycerate kinase (PGK) is a key enzyme involved in cellular energy metabolism, catalyzing a critical step in glycolysis. It facilitates the reversible transfer of a phosphate group from 1,3-bisphosphoglycerate (1,3-BPG) to ADP, generating 3-phosphoglycerate and ATP. Beyond glycolysis, PGK participates in gluconeogenesis and has been identified as a "moonlighting" protein with roles in pathogenesis, nucleic acid interactions, tumorigenesis progression, cell death regulation, and viral replication. Humans express two isoforms: PGK1 and PGK2. Deficiencies/mutations can cause rare inherited disorders characterized by hemolytic anemia or neurological symptoms.
Catalyzes the reversible transfer of a phosphate group from 1,3-bisphosphoglycerate (1,3-BPG) to ADP, generating 3-phosphoglycerate and ATP. Orients substrates favorably for efficient phosphate transfer and stabilizes transition states during catalysis. Domain closure upon dual substrate binding creates an isolated environment optimal for reaction completion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate kinase (None).